ミシガン州における間質性肺疾患の臨床試験
ミシガン州内の拠点で、間質性肺疾患に関する16件の研究が参加者を募集しています。
ミシガン州内の都市
公式研究テキスト（英語）
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- University of Michigan, Ann Arbor
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- University of Michigan, Ann Arbor
被験者募集中第3相
40歳以上 · 全性別 · 2026/09/30更新 · NCT07201922Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
- Allen Park, Allen Park
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/08更新 · NCT07473700A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Ann Arbor
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- Henry Ford Health, Detroit
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/04更新 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University of Michigan - Michigan Medicine, Ann Arbor
被験者募集中
18歳以上 · 全性別 · 2026/09/02更新 · NCT06911632A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Ann Arbor
- Clinical Research Site, Detroit
被験者募集中第2相
18歳〜85歳 · 全性別 · 2026/09/02更新 · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Corewell Health Beamont Troy Hospital, Troy
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/26更新 · NCT06388421PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
- University of Michigan, Ann Arbor
被験者募集中観察研究
18歳〜80歳 · 全性別 · 2026/08/18更新 · NCT06855329Platform Clinical Study for Conquering Scleroderma
- University of Michigan, Ann Arbor
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/18更新 · NCT06195072RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- University of Michigan, Ann Arbor
被験者募集中第2/3相
18歳〜75歳 · 全性別 · 2026/08/17更新 · NCT06328777Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Henry Ford Health, Detroit
被験者募集中観察研究
21歳以上 · 全性別 · 2026/08/12更新 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- University of Michigan, Ann Arbor
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/08/10更新 · NCT07175038Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Corewell Health Grand Rapids Hospitals - Butterworth, Grand Rapids
- Beaumont Hospital, Royal Oak, Royal Oak
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/13更新 · NCT05943535A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
- Galderma Investigational Site # 8743, Ann Arbor
被験者募集中第2相
18歳以上 · 全性別 · 2026/03/31更新 · NCT07047690Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
- University of Michigan, Ann Arbor
被験者募集中観察研究
18歳〜90歳 · 全性別 · 2024/05/03更新 · NCT06397677ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。